Calcium Permeable-AMPA Receptors and Excitotoxicity in Neurological Disorders
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Excitotoxicity is one of the primary mechanisms of cell loss in a variety of diseases of the central and peripheral nervous systems. Other than the previously established signaling pathways of excitotoxicity, which depend on the excessive release of glutamate from axon terminals or over-activation of NMDA receptors (NMDARs), Ca 2+ influx-triggered excitotoxicity through Ca 2+-permeable (CP)-AMPA receptors (AMPARs) is detected in multiple disease models. In this review, both acute brain insults (e.g., brain trauma or spinal cord injury, ischemia) and chronic neurological disorders, including Epilepsy/Seizures, Huntington’s disease (HD), Parkinson’s disease (PD), Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS), chronic pain, and glaucoma, are discussed regarding the CP-AMPAR-mediated excitotoxicity. Considering the low expression or absence of CP-AMPARs in most cells, specific manipulation of the CP-AMPARs might be a more plausible strategy to delay the onset and progression of pathological alterations with fewer side effects than blocking NMDARs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MACDONALD, M. (1993) · Cell · doi:10.1016/0092-8674(93)90585-e · Cited by 8,366
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Arai, T., Hasegawa, M., Akiyama, H., Ikeda, K., Nonaka, T., Mori, H., Mann, D., Tsuchiya, K., Yoshida, M., Hashizume, Y., et al. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.093 · Cited by 2,732
Dong, X.-X., Wang, Y., & Qin, Z.-H. (2009) · Acta Pharmacologica Sinica · doi:10.1038/aps.2009.24 · Cited by 1,297
Geiger, J. R. P., Melcher, T., Koh, D.-S., Sakmann, B., Seeburg, P. H., Jonas, P., & Monyer, H. (1995) · Neuron · doi:10.1016/0896-6273(95)90076-4 · Cited by 1,260
Shi, S.-H., Hayashi, Y., Esteban, J. A., & Malinow, R. (2001) · Cell · doi:10.1016/s0092-8674(01)00321-x · Cited by 1,094
Burnashev, N., Monyer, H., Seeburg, P. H., & Sakmann, B. (1992) · Neuron · doi:10.1016/0896-6273(92)90120-3 · Cited by 1,087
Regulatory phosphorylation of AMPA-type glutamate receptors by CaM-KII during long-term potentiation
Barria, A., Muller, D., Derkach, V., Griffith, L. C., & Soderling, T. R. (1997) · Science · doi:10.1126/science.276.5321.2042 · Cited by 1,049 · cited 1×
“Besides PKC, other kinases, such as PKA and CaMKII, have also been reported in phosphorylating GluA1 subunits in chronic pain models (Barria et al., 1997; Choi et al., 2010; Peng et al., 2011).”
BackgroundRole of Glutamate and NMDA Receptors in Alzheimer’s Disease
Wang, R., & Reddy, P. H. (2017) · Journal of Alzheimer’s Disease · doi:10.3233/jad-160763 · Cited by 1,009
Higuchi, M., Maas, S., Single, F. N., Hartner, J., Rozov, A., Burnashev, N., Feldmeyer, D., Sprengel, R., & Seeburg, P. H. (2000) · Nature · doi:10.1038/35017558 · Cited by 967
Evidence for multiple AMPA receptor complexes in hippocampal CA1/CA2 neurons
Wenthold, R., Petralia, R., Blahos J, II, & Niedzielski, A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-06-01982.1996 · Cited by 850 · cited 1×
“CP-AMPARs are expressed transiently at high levels in synaptic membranes at the early developmental stage, followed by a significant drop in mature neurons (Wenthold et al., 1996; Rozov et al., 2012).”
BackgroundThe Role of NMDA Receptors in Alzheimer’s Disease
Liu, J., Chang, L., Song, Y., Li, H., & Wu, Y. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00043 · Cited by 535
Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death
Liu, S. J., & Zukin, R. S. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.01.006 · Cited by 530 · cited 2×
“Within the TMD2, the GluA2 subunit usually contains the positively charged arginine (R) residue at the Q/R site, which is not encoded at the genomic level but arises owing to RNA editing (Liu and Zukin, 2007).”
BackgroundIino, M., Ozawa, S., & Tsuzuki, K. (1990) · The Journal of Physiology · doi:10.1113/jphysiol.1990.sp018060 · Cited by 497 · cited 1×
“The impermeability of AMPARs to Ca2+ was challenged by the observation that, besides the low Ca2+ permeable AMPARs, AMPARs with high permeability exist in a small, unidentified subset of cultured hippocampal neurons (Iino et al., 1990).”
BackgroundRole of ampa receptor endocytosis in synaptic plasticity
Carroll, R. C., Beattie, E. C., von Zastrow, M., & Malenka, R. C. (2001) · Nature Reviews Neuroscience · doi:10.1038/35072500 · Cited by 448
Sensi, S. L., Yin, H. Z., Carriedo, S. G., Rao, S. S., & Weiss, J. H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2414 · Cited by 408
Ma, Y.-Y., Lee, B. R., Wang, X., Guo, C., Liu, L., Cui, R., Lan, Y., Balcita-Pedicino, J. J., Wolf, M. E., Sesack, S. R., et al. (2014) · Neuron · doi:10.1016/j.neuron.2014.08.023 · Cited by 344
Self-citationCalcium-permeable AMPA channels in neurodegenerative disease and ischemia
Kwak, S., & Weiss, J. H. (2006) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2006.05.004 · Cited by 256 · cited 3×
“…probability of being detected in mature brains unless there are associated pathological events such as epilepsy (Malkin et al., 2016; Sun et al., 2018), ischemia (Noh et al., 2005; Kwak and Weiss, 2006), traumatic brain injury (Spaethling et al., 2008) and drug abuse (Ma et al., 2014, 2016, etc.).”
BackgroundSynaptic transmission and plasticity in the absence of AMPA glutamate receptor GluR2 and GluR3
Meng, Y., Zhang, Y., & Jia, Z. (2003) · Neuron · doi:10.1016/s0896-6273(03)00368-4 · Cited by 251
A further update on the role of excitotoxicity in the pathogenesis of Parkinson’s disease
Ambrosi, G., Cerri, S., & Blandini, F. (2014) · Journal of Neural Transmission · doi:10.1007/s00702-013-1149-z · Cited by 195 · cited 2×
“Parkinson’s disease (PD) is an age-related disorder caused by the degeneration and loss of dopaminergic neurons within the substantia nigra pars compacta (Ambrosi et al., 2014).”
BackgroundAkbarian, S., Smith, M. A., & Jones, E. G. (1995) · Brain Research · doi:10.1016/0006-8993(95)00922-d · Cited by 183
Alzheimer’s disease and related dementias increase costs of comorbidities in managed Medicare
Hill, J. W., Futterman, R., Duttagupta, S., Mastey, V., Lloyd, J. R., & Fillit, H. (2002) · Neurology · doi:10.1212/wnl.58.1.62 · Cited by 181 · cited 1×
“…in excitotoxicity, which is Frontiers in Neural Circuits | www.frontiersin.org 1 August 2021 | Volume 15 | Article 711564 an irreversible pathological neural alteration widely detected in neurological disorders (Dong et al., 2009; Selvaraj et al., 2018; Ghirardini et al., 2020; Hu et al., 2020).”
BackgroundLiu, Y., Cheng, A., Li, Y.-J., Yang, Y., Kishimoto, Y., Zhang, S., Wang, Y., Wan, R., Raefsky, S. M., Lu, D., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-09897-1 · Cited by 176
GluA2-lacking, calcium-permeable AMPA receptors--inducers of plasticity?
Man, H.-Y. (2011) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.01.001 · Cited by 142 · cited 1×
“CP-AMPARs are mostly atypical AMPARs, which are different from GluA2-containing Ca2+ impermeable (CI)-AMPARs that are typically found in the mature brain (Man, 2011).”
BackgroundCueva Vargas, J. L., Osswald, I. K., Unsain, N., Aurousseau, M. R., Barker, P. A., Bowie, D., & Di Polo, A. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.1273-15.2015 · Cited by 132 · cited 2×
“Another example is that the transmembrane AMPA receptor regulatory proteins (TARPs) play different roles in delivering CP-AMPARs, relative to nonCP-AMPARs (Cull-Candy and Farrant, 2021).”
BackgroundNew developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Jia, Y., Jeng, J., Sensi, S. L., & Weiss, J. H. (2002) · The Journal of Physiology · doi:10.1113/jphysiol.2002.020172 · Cited by 118 · cited 1×
“In fact, CP-AMPARs increase significantly in diseased states and they are permeable to Zn2+, which can trigger mitochondrial dysfunction and cell death (Sensi et al., 1999; Jia et al., 2002; Redman et al., 2009; Huang et al., 2011).”
BackgroundSpaethling, J. M., Klein, D. M., Singh, P., & Meaney, D. F. (2008) · Journal of Neurotrauma · doi:10.1089/neu.2008.0532 · Cited by 112
Goforth, P. B., Ren, J., Schwartz, B. S., & Satin, L. S. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00467.2010 · Cited by 69 · cited 1×
“…of the synapses as a storage of this critical subunit, serving for at least two functions including, first, to ensure the availability of GluA2 for AMPA receptor assembly, and second, to facilitate incorporation of GluA2 subunits during AMPAR assembly (Greger et al., 2002; Pick and Ziff, 2018).”
BackgroundYi, E.-S., Oh, S., Lee, J.-K., & Leem, Y.-H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.03.093 · Cited by 45 · cited 1×
“For example, CP-AMPAR increase in the amygdala was related to anxiety (Yi et al., 2017); in the lateral habenula it was linked to depression (Zhang et al.”
BackgroundDistinct AMPA-Type Glutamatergic Synapses in Developing Rat CA1 Hippocampus
Stubblefield, E. A., & Benke, T. A. (2010) · Journal of Neurophysiology · doi:10.1152/jn.00099.2010 · Cited by 38
Spaethling, J., Le, L., & Meaney, D. F. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.03.003 · Cited by 36 · cited 1×
“…different neuronal populations indicates that CPAMPAR-mediated cell loss is not unique to one model system or one specific region, but is broadly implicated in the neuronal responses to traumatic injury of the CNS and PNS (Goforth et al., 2011; Spaethling et al., 2012; Korgaonkar et al., 2020).”
Background
Cited by
Nimgampalle, M., Chakravarthy, H., Sharma, S., Shree, S., Bhat, A. R., Pradeepkiran, J. A., & Devanathan, V. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101994 · Cited by 207
Mitochondrial calcium cycling in neuronal function and neurodegeneration
Walters, G. C., & Usachev, Y. M. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1094356 · Cited by 105
“Glutamate-induced Ca entry, largely via NMDA as well as Ca-permeable AMPA glutamate receptors, mitochondrial Ca overload and Ca deregulation initiate neurotoxic cascades through many mechanisms, including rupture of mitochondrial membranes, mitochondrial depolarization, ROS generation and opening of mitochondrial perm…”
BackgroundPICALM and Alzheimer’s Disease: An Update and Perspectives
Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104
AMPA Receptors in Synaptic Plasticity, Memory Function, and Brain Diseases
de León-López, C. A. M., Carretero-Rey, M., & Khan, Z. U. (2025) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-024-01529-7 · Cited by 73
“This elevated calcium influx induces neuronal overactivation, ultimately resulting in excitotoxicity and cell death (Bennett et al. 1996; Guo and Ma 2021).”
Suriano, C. M., Kumar, N., Verpeut, J. L., Ma, J., Jung, C., Dunn, C. E., Carvajal, B. V., Nguyen, A. V., & Boulanger, L. M. (2024) · Molecular Therapy · doi:10.1016/j.ymthe.2024.03.036 · Cited by 21
“43 As expected, NASPM blocked only a small fraction (5.1”
Influential
Metadata
- Authors
- Guo, C., & Ma, Y.-Y.
- Venue
- Frontiers in Neural Circuits
- Publisher
- Frontiers Media SA
- Published
- 2021-08-17
- Volume
- 15
- Pages
- 711564-711564
- ISSN
- 1662-5110 (ISSN-L)
- OpenAlex
- W3193341716
- Cited by
- 181
- References
- 32
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.